BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30027669)

  • 1. Clinical and genetic ancestry profile of a large multi-centre sickle cell disease cohort in Brazil.
    Carneiro-Proietti ABF; Kelly S; Miranda Teixeira C; Sabino EC; Alencar CS; Capuani L; Salomon Silva TP; Araujo A; Loureiro P; Máximo C; Lobo C; Flor-Park MV; Rodrigues DOW; Mota RA; Gonçalez TT; Hoppe C; Ferreira JE; Ozahata M; Page GP; Guo Y; Preiss LR; Brambilla D; Busch MP; Custer B;
    Br J Haematol; 2018 Sep; 182(6):895-908. PubMed ID: 30027669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of an automated pyrosequencing technique for confirmation of sickle cell disease.
    de Martino CC; Alencar CS; Loureiro P; Carneiro-Proietti ABF; Máximo CA; Mota RA; Rodrigues DOW; Gaburo Junior N; Kelly S; Sabino EC;
    PLoS One; 2019; 14(12):e0216020. PubMed ID: 31830127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Genetic Predictors of Priapism in Sickle Cell Disease: Results from the Recipient Epidemiology and Donor Evaluation Study III Brazil Cohort Study.
    Cintho Ozahata M; Page GP; Guo Y; Ferreira JE; Dinardo CL; Carneiro-Proietti ABF; Loureiro P; Mota RA; Rodrigues DOW; Belisario AR; Maximo C; Flor-Park MV; Custer B; Kelly S; Sabino EC;
    J Sex Med; 2019 Dec; 16(12):1988-1999. PubMed ID: 31668730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in genes that affect the variation of lipid levels in a Brazilian pediatric population with sickle cell disease: rs662799 APOA5 and rs964184 ZPR1.
    Valente-Frossard TNS; Cruz NRC; Ferreira FO; Belisario AR; Pereira BM; Gomides AFF; Resende GAD; Carlos AM; Moraes-Souza H; Velloso-Rodrigues C
    Blood Cells Mol Dis; 2020 Feb; 80():102376. PubMed ID: 31670185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island.
    Muszlak M; Pissard S; Badens C; Chamouine A; Maillard O; Thuret I
    Hemoglobin; 2015; 39(3):156-61. PubMed ID: 25806420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Nevitt SJ; Jones AP; Howard J
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood.
    Hankins JS; Estepp JH; Hodges JR; Villavicencio MA; Robison LL; Weiss MJ; Kang G; Schreiber JE; Porter JS; Kaste SC; Saving KL; Bryant PC; Deyo JE; Nottage KA; King AA; Brandow AM; Lebensburger JD; Adesina O; Chou ST; Zemel BS; Smeltzer MP; Wang WC; Gurney JG
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27228. PubMed ID: 29797644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
    Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between haematological parameters and sickle cell genotypes in children with Plasmodium falciparum malaria resident in Kisumu County in Western Kenya.
    Kosiyo P; Otieno W; Gitaka J; Munde EO; Ouma C
    BMC Infect Dis; 2020 Nov; 20(1):887. PubMed ID: 33238928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
    Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
    Sales RR; Belisário AR; Faria G; Mendes F; Luizon MR; Viana MB
    Ann Hematol; 2020 Jul; 99(7):1453-1463. PubMed ID: 32447424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide association study of erythrocyte density in sickle cell disease patients.
    Ilboudo Y; Bartolucci P; Rivera A; Sedzro JC; Beaudoin M; Trudel M; Alper SL; Brugnara C; Galactéros F; Lettre G
    Blood Cells Mol Dis; 2017 Jun; 65():60-65. PubMed ID: 28552477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatographic analysis of Hb S for the diagnosis of various sickle cell disorders in Pakistan.
    Hashmi NK; Moiz B; Nusrat M; Hashmi MR
    Ann Hematol; 2008 Aug; 87(8):639-45. PubMed ID: 18465131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hb F Levels in Indian Sickle Cell Patients and Association with the HBB Locus Variant rs10128556 (C>T), and the HBG XmnI (Arab-Indian) Variant.
    Bhanushali AA; Himani K; Patra PK; Das BR
    Hemoglobin; 2017; 41(4-6):317-320. PubMed ID: 29313433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial Aneurysms in Sickle-Cell Disease Are Associated With the Hemoglobin SS Genotype But Not With Moyamoya Syndrome.
    Birkeland P; Gardner K; Kesse-Adu R; Davies J; Lauritsen J; Rom Poulsen F; Tolias CM; Thein SL
    Stroke; 2016 Jul; 47(7):1710-3. PubMed ID: 27301940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hb S/
    Belisário AR; Carneiro-Proietti AB; Sabino EC; Araújo A; Loureiro P; Máximo C; Flor-Park MV; Rodrigues DDOW; Ozahata MC; McClure C; Mota RA; Gomes Moura IC; Custer B; Kelly S;
    Hemoglobin; 2020 Jan; 44(1):1-9. PubMed ID: 32172616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical correlates of steady-state oxyhaemoglobin desaturation in children who have sickle cell disease.
    Quinn CT; Ahmad N
    Br J Haematol; 2005 Oct; 131(1):129-34. PubMed ID: 16173973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse clinical and obstetric outcomes among pregnant women with different sickle cell disease genotypes.
    Silva FAC; Ferreira ALCG; Hazin-Costa MF; Dias MLG; Araújo AS; Souza AI
    Int J Gynaecol Obstet; 2018 Oct; 143(1):89-93. PubMed ID: 30030929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database.
    Isa H; Adegoke S; Madu A; Hassan AA; Ohiaeri C; Chianumba R; Brown B; Okocha E; Ugwu N; Diaku-Akinwumi I; Adeyemo T; Kuliya-Gwarzo A; Dogara L; Lawal H; Tanko Y; Ladu A; Kangiwa U; Ekwem L; Oniyangi S; Wakama T; Umoru D; Olanrewaju O; Akinola N; Nnebe-Agumadu U; Asala S; Adekile A; Olaniyi J; Sangeda R; Sickle Africa Data Coordinating Center SADaCC ; Nnodu O
    Blood Cells Mol Dis; 2020 Sep; 84():102438. PubMed ID: 32504882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
    El-Ghamrawy M; Yassa ME; Tousson AMS; El-Hady MA; Mikhaeil E; Mohamed NB; Khorshied MM
    Ann Hematol; 2020 Oct; 99(10):2279-2288. PubMed ID: 32772141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.